"10.1371_journal.pone.0069773","plos one","2013-07-30T00:00:00Z","Olga Abian; Sonia Vega; Javier Sancho; Adrian Velazquez-Campoy","Institute of Biocomputation and Physics of Complex Systems (BIFI), Joint Unit IQFR-CSIC-BIFI, Universidad de Zaragoza, Zaragoza, Spain; IIS Aragón, Instituto Aragonés de Ciencias de la Salud, Zaragoza, Spain; Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain; Department of Biochemistry and Molecular and Cell Biology, Universidad de Zaragoza, Zaragoza, Spain; Fundación ARAID, Government of Aragon, Zaragoza, Spain","Conceived and designed the experiments: OA AVC. Performed the experiments: OA SV. Analyzed the data: OA SV JS AVC. Contributed reagents/materials/analysis tools: OA JS AVC. Wrote the paper: OA SV JS AVC.","OA, SV, JS, and AVC have a patent pending on the use of the identified compounds in the treatment of HCV infection. The recently registered patent application is, as follows: EP12382218.1 Allosteric Inhibitors of NS3 Protease from Hepatitis C Virus. This fact does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Olga Abian","OA",4,TRUE,2,2,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
